These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30560428)

  • 1. Solid-State Characterization of Three Polymorphs of an Orally Available Analog of Diethylenetriaminepentaacetic Acid.
    Coste Sanchez C; Kalra A; Li T; Jay M
    AAPS PharmSciTech; 2018 Dec; 20(1):8. PubMed ID: 30560428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of two polymorphs of salmeterol xinafoate crystallized from supercritical fluids.
    Tong HH; Shekunov BY; York P; Chow AH
    Pharm Res; 2001 Jun; 18(6):852-8. PubMed ID: 11474791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and Physicochemical Characterization of a Diethyl Ester Prodrug of DTPA and Its Investigation as an Oral Decorporation Agent in Rats.
    Huckle JE; Sadgrove MP; Leed MG; Yang YT; Mumper RJ; Semelka RC; Jay M
    AAPS J; 2016 Jul; 18(4):972-80. PubMed ID: 27106838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of two polymorphic forms of imatinib mesylate in a drug substance and tablet formulation by X-ray powder diffraction, differential scanning calorimetry and attenuated total reflectance Fourier transform infrared spectroscopy.
    Bellur Atici E; Karlığa B
    J Pharm Biomed Anal; 2015 Oct; 114():330-40. PubMed ID: 26099262
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preparation and characterization of a novel polymorph of indiplon, Form α.
    Xu L; Wang J; Xiao B; Yang J; Liu Y; Huang R
    Bioorg Med Chem Lett; 2012 Jan; 22(2):963-8. PubMed ID: 22209207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of polymorphs for an LTD4 antagonist, RG 12525.
    Carlton RA; Difeo TJ; Powner TH; Santos I; Thompson MD
    J Pharm Sci; 1996 May; 85(5):461-7. PubMed ID: 8742935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization, selection, and development of an orally dosed drug polymorph from an enantiotropically related system.
    Katrincic LM; Sun YT; Carlton RA; Diederich AM; Mueller RL; Vogt FG
    Int J Pharm; 2009 Jan; 366(1-2):1-13. PubMed ID: 18824090
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Solid state properties of an oral iron chelator, 1,2-dimethyl-3-hydroxy-4-pyridone, and its acetic acid solvate. I: Physicochemical characterization, intrinsic dissolution rate, and solution thermodynamics.
    Chan HK; Venkataram S; Grant DJ; Rahman YE
    J Pharm Sci; 1991 Jul; 80(7):677-85. PubMed ID: 1941568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissolution properties, solid-state transformation and polymorphic crystallization: progesterone case study.
    Araya-Sibaja AM; Paulino AS; Rauber GS; Campos CE; Cardoso SG; Monti GA; Heredia V; Bianco I; Beltrano D; Cuffini SL
    Pharm Dev Technol; 2014 Nov; 19(7):779-88. PubMed ID: 24032356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of phenylbutazone: properties and compressional behavior of crystals.
    Ibrahim HG; Pisano F; Bruno A
    J Pharm Sci; 1977 May; 66(5):669-73. PubMed ID: 874748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Solid-state characterization of rifampicin samples and its biopharmaceutic relevance.
    Agrawal S; Ashokraj Y; Bharatam PV; Pillai O; Panchagnula R
    Eur J Pharm Sci; 2004 Jun; 22(2-3):127-44. PubMed ID: 15158898
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid state characterization of E2101, a novel antispastic drug.
    Kushida I; Ashizawa K
    J Pharm Sci; 2002 Oct; 91(10):2193-202. PubMed ID: 12226846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubility and crystal nucleation in organic solvents of two polymorphs of curcumin.
    Liu J; Svärd M; Hippen P; Rasmuson ÅC
    J Pharm Sci; 2015 Jul; 104(7):2183-9. PubMed ID: 25950658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubility and thermodynamic analysis of famotidine polymorphs in pure solvents.
    Soto R; Svärd M
    Int J Pharm; 2021 Sep; 607():121031. PubMed ID: 34419593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantification of polymorphic impurity in an enantiotropic polymorph system using differential scanning calorimetry, X-ray powder diffraction and Raman spectroscopy.
    Li Y; Chow PS; Tan RB
    Int J Pharm; 2011 Aug; 415(1-2):110-8. PubMed ID: 21645601
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Solid-state form screen of cardiosulfa and its analogues.
    Kumar SS; Rana S; Nangia A
    Chem Asian J; 2013 Jul; 8(7):1551-68. PubMed ID: 23616361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Solid state characterizations and analysis of stability in azelnidipine polymorphs.
    Li D; Wang M; Yang C; Wang J; Ren G
    Chem Pharm Bull (Tokyo); 2012; 60(8):995-1002. PubMed ID: 22863703
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures and physicochemical properties of amisulpride polymorphs.
    Zhang WP; Chen DY
    J Pharm Biomed Anal; 2017 Jun; 140():252-257. PubMed ID: 28371719
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding the polymorphic behavior of sibenadet hydrochloride through detailed studies integrating structural and dynamical assessment.
    Cosgrove SD; Steele G; Austin TK; Plumb AP; Stensland B; Ferrari E; Roberts KJ
    J Pharm Sci; 2005 Nov; 94(11):2403-15. PubMed ID: 16200581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An insight into thermodynamic relationship between polymorphic forms of efavirenz.
    Chadha R; Arora P; Saini A; Singh Jain D
    J Pharm Pharm Sci; 2012; 15(2):234-51. PubMed ID: 22579003
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.